ReviewAdvances in cancer research2022
Targeting the "undruggable" RAS with biologics.
Michael Whaby et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewAdvances in cancer research2022
Michael Whaby et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.